再狭窄
祖细胞
经皮冠状动脉介入治疗
传统PCI
医学
内皮祖细胞
支架
心脏病学
冠状动脉疾病
内皮干细胞
内皮
狭窄
内科学
干细胞
心肌梗塞
细胞生物学
生物
生物化学
体外
作者
Bocheng Xu,Meixiang Xiang,Jianan Wang
出处
期刊:Current stem cell research & therapy
[Bentham Science]
日期:2015-05-13
卷期号:10 (4): 364-371
被引量:17
标识
DOI:10.2174/1574888x10666150204150430
摘要
Coronary artery disease (CAD) is a significant global health problem, contributing to significant morbidity and mortality. Percutaneous coronary intervention (PCI) is an efficient therapy for treating CAD, but it carries the risk of iatrogenic endothelial injury, which contributes to vessel inflammation and induction of in-stent restenosis. Therefore, developing novel methods for enhancing re-endothelialization after PCI is highly needed. Endothelial progenitor cells (EPCs) can differentiate into mature endothelial cells, and cell therapy with EPC may offer a novel way for accelerating reendothelialization. In this review paper, we aimed to briefly describe EPCs and highlight their potential therapeutic roles in in-stent re-stenosis and endothelial injury. Keywords: Coronary heart disease, endothelial cell, endothelial progenitor cell, endothelium injury, percutaneous coronary intervention, in-stent restenosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI